Global and Japan Cancer Tumor Profiling Market Size, Status and Forecast 2020-2026

Global and Japan Cancer Tumor Profiling Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Next-generation Sequencing (NGS)
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Immunohistochemistry (IHC)
1.2.5 In Situ Hybridization (ISH)
1.2.6 Microarray
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cancer Tumor Profiling Market Share by Application: 2020 VS 2026
1.3.2 Personalized Medicine
1.3.3 Diagnostics
1.3.4 Biomarker Discovery
1.3.5 Prognostics
1.3.6 Research Applications
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Tumor Profiling Market Perspective (2015-2026)
2.2 Global Cancer Tumor Profiling Growth Trends by Regions
2.2.1 Cancer Tumor Profiling Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Tumor Profiling Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Tumor Profiling Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Tumor Profiling Players by Market Size
3.1.1 Global Top Cancer Tumor Profiling Players by Revenue (2015-2020)
3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Players (2015-2020)
3.2 Global Cancer Tumor Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Tumor Profiling Revenue
3.4 Global Cancer Tumor Profiling Market Concentration Ratio
3.4.1 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Tumor Profiling Revenue in 2019
3.5 Key Players Cancer Tumor Profiling Area Served
3.6 Key Players Cancer Tumor Profiling Product Solution and Service
3.7 Date of Enter into Cancer Tumor Profiling Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Tumor Profiling Breakdown Data by Type (2015-2026)
4.1 Global Cancer Tumor Profiling Historic Market Size by Type (2015-2020)
4.2 Global Cancer Tumor Profiling Forecasted Market Size by Type (2021-2026)
5 Cancer Tumor Profiling Breakdown Data by Application (2015-2026)
5.1 Global Cancer Tumor Profiling Historic Market Size by Application (2015-2020)
5.2 Global Cancer Tumor Profiling Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Tumor Profiling Market Size (2015-2026)
6.2 North America Cancer Tumor Profiling Market Size by Type (2015-2020)
6.3 North America Cancer Tumor Profiling Market Size by Application (2015-2020)
6.4 North America Cancer Tumor Profiling Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Cancer Tumor Profiling Market Size (2015-2026)
7.2 Europe Cancer Tumor Profiling Market Size by Type (2015-2020)
7.3 Europe Cancer Tumor Profiling Market Size by Application (2015-2020)
7.4 Europe Cancer Tumor Profiling Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Cancer Tumor Profiling Market Size (2015-2026)
8.2 China Cancer Tumor Profiling Market Size by Type (2015-2020)
8.3 China Cancer Tumor Profiling Market Size by Application (2015-2020)
8.4 China Cancer Tumor Profiling Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Cancer Tumor Profiling Market Size (2015-2026)
9.2 Japan Cancer Tumor Profiling Market Size by Type (2015-2020)
9.3 Japan Cancer Tumor Profiling Market Size by Application (2015-2020)
9.4 Japan Cancer Tumor Profiling Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Cancer Tumor Profiling Market Size (2015-2026)
10.2 Southeast Asia Cancer Tumor Profiling Market Size by Type (2015-2020)
10.3 Southeast Asia Cancer Tumor Profiling Market Size by Application (2015-2020)
10.4 Southeast Asia Cancer Tumor Profiling Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Details
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Cancer Tumor Profiling Introduction
11.1.4 Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2015-2020))
11.1.5 Qiagen N.V. Recent Development
11.2 Roche Molecular Systems Inc.
11.2.1 Roche Molecular Systems Inc. Company Details
11.2.2 Roche Molecular Systems Inc. Business Overview
11.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Introduction
11.2.4 Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
11.2.5 Roche Molecular Systems Inc. Recent Development
11.3 Abott Molecular
11.3.1 Abott Molecular Company Details
11.3.2 Abott Molecular Business Overview
11.3.3 Abott Molecular Cancer Tumor Profiling Introduction
11.3.4 Abott Molecular Revenue in Cancer Tumor Profiling Business (2015-2020)
11.3.5 Abott Molecular Recent Development
11.4 Illumina Inc.
11.4.1 Illumina Inc. Company Details
11.4.2 Illumina Inc. Business Overview
11.4.3 Illumina Inc. Cancer Tumor Profiling Introduction
11.4.4 Illumina Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
11.4.5 Illumina Inc. Recent Development
11.5 NeoGenomics Laboratories
11.5.1 NeoGenomics Laboratories Company Details
11.5.2 NeoGenomics Laboratories Business Overview
11.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Introduction
11.5.4 NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2015-2020)
11.5.5 NeoGenomics Laboratories Recent Development
11.6 HTG Molecular Diagnostic
11.6.1 HTG Molecular Diagnostic Company Details
11.6.2 HTG Molecular Diagnostic Business Overview
11.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Introduction
11.6.4 HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2015-2020)
11.6.5 HTG Molecular Diagnostic Recent Development
11.7 Genomic Health Inc.
11.7.1 Genomic Health Inc. Company Details
11.7.2 Genomic Health Inc. Business Overview
11.7.3 Genomic Health Inc. Cancer Tumor Profiling Introduction
11.7.4 Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
11.7.5 Genomic Health Inc. Recent Development
11.8 Hologic Gen-Probe
11.8.1 Hologic Gen-Probe Company Details
11.8.2 Hologic Gen-Probe Business Overview
11.8.3 Hologic Gen-Probe Cancer Tumor Profiling Introduction
11.8.4 Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2015-2020)
11.8.5 Hologic Gen-Probe Recent Development
11.9 BD Biosciences
11.9.1 BD Biosciences Company Details
11.9.2 BD Biosciences Business Overview
11.9.3 BD Biosciences Cancer Tumor Profiling Introduction
11.9.4 BD Biosciences Revenue in Cancer Tumor Profiling Business (2015-2020)
11.9.5 BD Biosciences Recent Development
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Details
11.10.2 Siemens Healthineers Business Overview
11.10.3 Siemens Healthineers Cancer Tumor Profiling Introduction
11.10.4 Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2015-2020)
11.10.5 Siemens Healthineers Recent Development
11.11 Claris Life Sciences
10.11.1 Claris Life Sciences Company Details
10.11.2 Claris Life Sciences Business Overview
10.11.3 Claris Life Sciences Cancer Tumor Profiling Introduction
10.11.4 Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2015-2020)
10.11.5 Claris Life Sciences Recent Development
11.12 Personal Genome Diagnostics, Inc.
10.12.1 Personal Genome Diagnostics, Inc. Company Details
10.12.2 Personal Genome Diagnostics, Inc. Business Overview
10.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Introduction
10.12.4 Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
10.12.5 Personal Genome Diagnostics, Inc. Recent Development
11.13 Perthera, Inc.
10.13.1 Perthera, Inc. Company Details
10.13.2 Perthera, Inc. Business Overview
10.13.3 Perthera, Inc. Cancer Tumor Profiling Introduction
10.13.4 Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
10.13.5 Perthera, Inc. Recent Development
11.14 Foundation Medicine, Inc
10.14.1 Foundation Medicine, Inc Company Details
10.14.2 Foundation Medicine, Inc Business Overview
10.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Introduction
10.14.4 Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2015-2020)
10.14.5 Foundation Medicine, Inc Recent Development
11.15 V., Strand
10.15.1 V., Strand Company Details
10.15.2 V., Strand Business Overview
10.15.3 V., Strand Cancer Tumor Profiling Introduction
10.15.4 V., Strand Revenue in Cancer Tumor Profiling Business (2015-2020)
10.15.5 V., Strand Recent Development
11.16 ApoCell
10.16.1 ApoCell Company Details
10.16.2 ApoCell Business Overview
10.16.3 ApoCell Cancer Tumor Profiling Introduction
10.16.4 ApoCell Revenue in Cancer Tumor Profiling Business (2015-2020)
10.16.5 ApoCell Recent Development
11.17 Contextual Genomics
10.17.1 Contextual Genomics Company Details
10.17.2 Contextual Genomics Business Overview
10.17.3 Contextual Genomics Cancer Tumor Profiling Introduction
10.17.4 Contextual Genomics Revenue in Cancer Tumor Profiling Business (2015-2020)
10.17.5 Contextual Genomics Recent Development
11.18 Agendia
10.18.1 Agendia Company Details
10.18.2 Agendia Business Overview
10.18.3 Agendia Cancer Tumor Profiling Introduction
10.18.4 Agendia Revenue in Cancer Tumor Profiling Business (2015-2020)
10.18.5 Agendia Recent Development
11.19 GenScript
10.19.1 GenScript Company Details
10.19.2 GenScript Business Overview
10.19.3 GenScript Cancer Tumor Profiling Introduction
10.19.4 GenScript Revenue in Cancer Tumor Profiling Business (2015-2020)
10.19.5 GenScript Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cancer Tumor Profiling Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Next-generation Sequencing (NGS)
Table 4. Key Players of Polymerase Chain Reaction (PCR)
Table 5. Key Players of Immunohistochemistry (IHC)
Table 6. Key Players of In Situ Hybridization (ISH)
Table 7. Key Players of Microarray
Table 8. Key Players of Others
Table 9. Global Cancer Tumor Profiling Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Cancer Tumor Profiling Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Cancer Tumor Profiling Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Cancer Tumor Profiling Market Share by Regions (2015-2020)
Table 13. Global Cancer Tumor Profiling Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Cancer Tumor Profiling Market Share by Regions (2021-2026)
Table 15. Cancer Tumor Profiling Market Market Trends
Table 16. Cancer Tumor Profiling Market Drivers
Table 17. Cancer Tumor Profiling Market Challenges
Table 18. Cancer Tumor Profiling Market Restraints
Table 19. Global Cancer Tumor Profiling Revenue by Players (2015-2020) (US$ Million)
Table 20. Global Cancer Tumor Profiling Market Share by Players (2015-2020)
Table 21. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tumor Profiling as of 2019)
Table 22. Global Cancer Tumor Profiling by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Tumor Profiling Product Solution and Service
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Tumor Profiling Market Size by Type (2015-2020) (US$ Million)
Table 27. Global Cancer Tumor Profiling Market Size Share by Type (2015-2020)
Table 28. Global Cancer Tumor Profiling Revenue Market Share by Type (2021-2026)
Table 29. Global Cancer Tumor Profiling Market Size Share by Application (2015-2020)
Table 30. Global Cancer Tumor Profiling Market Size by Application (2015-2020) (US$ Million)
Table 31. Global Cancer Tumor Profiling Market Size Share by Application (2021-2026)
Table 32. North America Cancer Tumor Profiling Market Size by Type (2015-2020) (US$ Million)
Table 33. North America Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 34. North America Cancer Tumor Profiling Market Size by Application (2015-2020) (US$ Million)
Table 35. North America Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 36. North America Cancer Tumor Profiling Market Size by Country (US$ Million) (2015-2020)
Table 37. North America Cancer Tumor Profiling Market Share by Country (2015-2020)
Table 38. Europe Cancer Tumor Profiling Market Size by Type (2015-2020) (US$ Million)
Table 39. Europe Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 40. Europe Cancer Tumor Profiling Market Size by Application (2015-2020) (US$ Million)
Table 41. Europe Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 42. Europe Cancer Tumor Profiling Market Size by Country (US$ Million) (2015-2020)
Table 43. Europe Cancer Tumor Profiling Market Share by Country (2015-2020)
Table 44. China Cancer Tumor Profiling Market Size by Type (2015-2020) (US$ Million)
Table 45. China Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 46. China Cancer Tumor Profiling Market Size by Application (2015-2020) (US$ Million)
Table 47. China Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 48. China Cancer Tumor Profiling Market Size by Region (US$ Million) (2015-2020)
Table 49. China Cancer Tumor Profiling Market Share by Region (2015-2020)
Table 50. Japan Cancer Tumor Profiling Market Size by Type (2015-2020) (US$ Million)
Table 51. Japan Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 52. Japan Cancer Tumor Profiling Market Size by Application (2015-2020) (US$ Million)
Table 53. Japan Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 54. Japan Cancer Tumor Profiling Market Size by Country (US$ Million) (2015-2020)
Table 55. Japan Cancer Tumor Profiling Market Share by Country (2015-2020)
Table 56. Southeast Asia Cancer Tumor Profiling Market Size by Type (2015-2020) (US$ Million)
Table 57. Southeast Asia Cancer Tumor Profiling Market Share by Type (2015-2020)
Table 58. Southeast Asia Cancer Tumor Profiling Market Size by Application (2015-2020) (US$ Million)
Table 59. Southeast Asia Cancer Tumor Profiling Market Share by Application (2015-2020)
Table 60. Southeast Asia Cancer Tumor Profiling Market Size by Country (US$ Million) (2015-2020)
Table 61. Southeast Asia Cancer Tumor Profiling Market Share by Country (2015-2020)
Table 62. Qiagen N.V. Company Details
Table 63. Qiagen N.V. Business Overview
Table 64. Qiagen N.V. Product
Table 65. Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 66. Qiagen N.V. Recent Development
Table 67. Roche Molecular Systems Inc. Company Details
Table 68. Roche Molecular Systems Inc. Business Overview
Table 69. Roche Molecular Systems Inc. Product
Table 70. Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 71. Roche Molecular Systems Inc. Recent Development
Table 72. Abott Molecular Company Details
Table 73. Abott Molecular Business Overview
Table 74. Abott Molecular Product
Table 75. Abott Molecular Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 76. Abott Molecular Recent Development
Table 77. Illumina Inc. Company Details
Table 78. Illumina Inc. Business Overview
Table 79. Illumina Inc. Product
Table 80. Illumina Inc. Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 81. Illumina Inc. Recent Development
Table 82. NeoGenomics Laboratories Company Details
Table 83. NeoGenomics Laboratories Business Overview
Table 84. NeoGenomics Laboratories Product
Table 85. NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 86. NeoGenomics Laboratories Recent Development
Table 87. HTG Molecular Diagnostic Company Details
Table 88. HTG Molecular Diagnostic Business Overview
Table 89. HTG Molecular Diagnostic Product
Table 90. HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 91. HTG Molecular Diagnostic Recent Development
Table 92. Genomic Health Inc. Company Details
Table 93. Genomic Health Inc. Business Overview
Table 94. Genomic Health Inc. Product
Table 95. Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 96. Genomic Health Inc. Recent Development
Table 97. Hologic Gen-Probe Business Overview
Table 98. Hologic Gen-Probe Product
Table 99. Hologic Gen-Probe Company Details
Table 100. Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 101. Hologic Gen-Probe Recent Development
Table 102. BD Biosciences Company Details
Table 103. BD Biosciences Business Overview
Table 104. BD Biosciences Product
Table 105. BD Biosciences Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 106. BD Biosciences Recent Development
Table 107. Siemens Healthineers Company Details
Table 108. Siemens Healthineers Business Overview
Table 109. Siemens Healthineers Product
Table 110. Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 111. Siemens Healthineers Recent Development
Table 112. Claris Life Sciences Company Details
Table 113. Claris Life Sciences Business Overview
Table 114. Claris Life Sciences Product
Table 115. Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 116. Claris Life Sciences Recent Development
Table 117. Personal Genome Diagnostics, Inc. Company Details
Table 118. Personal Genome Diagnostics, Inc. Business Overview
Table 119. Personal Genome Diagnostics, Inc. Product
Table 120. Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 121. Personal Genome Diagnostics, Inc. Recent Development
Table 122. Perthera, Inc. Company Details
Table 123. Perthera, Inc. Business Overview
Table 124. Perthera, Inc. Product
Table 125. Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 126. Perthera, Inc. Recent Development
Table 127. Foundation Medicine, Inc Company Details
Table 128. Foundation Medicine, Inc Business Overview
Table 129. Foundation Medicine, Inc Product
Table 130. Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 131. Foundation Medicine, Inc Recent Development
Table 132. V., Strand Company Details
Table 133. V., Strand Business Overview
Table 134. V., Strand Product
Table 135. V., Strand Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 136. V., Strand Recent Development
Table 137. ApoCell Company Details
Table 138. ApoCell Business Overview
Table 139. ApoCell Product
Table 140. ApoCell Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 141. ApoCell Recent Development
Table 142. Contextual Genomics Company Details
Table 143. Contextual Genomics Business Overview
Table 144. Contextual Genomics Product
Table 145. Contextual Genomics Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 146. Contextual Genomics Recent Development
Table 147. Agendia Company Details
Table 148. Agendia Business Overview
Table 149. Agendia Product
Table 150. Agendia Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 151. Agendia Recent Development
Table 152. GenScript Company Details
Table 153. GenScript Business Overview
Table 154. GenScript Product
Table 155. GenScript Revenue in Cancer Tumor Profiling Business (2015-2020) (US$ Million)
Table 156. GenScript Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Tumor Profiling Market Share by Type: 2020 VS 2026
Figure 2. Next-generation Sequencing (NGS) Features
Figure 3. Polymerase Chain Reaction (PCR) Features
Figure 4. Immunohistochemistry (IHC) Features
Figure 5. In Situ Hybridization (ISH) Features
Figure 6. Microarray Features
Figure 7. Others Features
Figure 8. Global Cancer Tumor Profiling Market Share by Application: 2020 VS 2026
Figure 9. Personalized Medicine Case Studies
Figure 10. Diagnostics Case Studies
Figure 11. Biomarker Discovery Case Studies
Figure 12. Prognostics Case Studies
Figure 13. Research Applications Case Studies
Figure 14. Cancer Tumor Profiling Report Years Considered
Figure 15. Global Cancer Tumor Profiling Market Size (US$ Million), YoY Growth 2015-2026
Figure 16. Global Cancer Tumor Profiling Market Share by Regions: 2020 VS 2026
Figure 17. Global Cancer Tumor Profiling Market Share by Regions (2021-2026)
Figure 18. Global Cancer Tumor Profiling Market Share by Players in 2019
Figure 19. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tumor Profiling as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Cancer Tumor Profiling Revenue in 2019
Figure 21. North America Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. United States Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Canada Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Europe Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Germany Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. France Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. U.K. Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Italy Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Russia Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Nordic Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Rest of Europe Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Asia-Pacific Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. China Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Japan Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. South Korea Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Southeast Asia Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. India Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Australia Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Rest of Asia-Pacific Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Latin America Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Mexico Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Brazil Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Middle East & Africa Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Turkey Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Saudi Arabia Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. UAE Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Rest of Middle East & Africa Cancer Tumor Profiling Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Qiagen N.V. Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 49. Roche Molecular Systems Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 50. Abott Molecular Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 51. Illumina Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 52. NeoGenomics Laboratories Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 53. HTG Molecular Diagnostic Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 54. Genomic Health Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 55. Hologic Gen-Probe Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 56. BD Biosciences Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 57. Siemens Healthineers Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 58. Claris Life Sciences Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 59. Personal Genome Diagnostics, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 60. Perthera, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 61. Foundation Medicine, Inc Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 62. V., Strand Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 63. ApoCell Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 64. Contextual Genomics Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 65. Agendia Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 66. GenScript Revenue Growth Rate in Cancer Tumor Profiling Business (2015-2020)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs